FAQ (Frequently Asked Questions)

Vaginal self-sampling consists of collecting a sample yourself, either at home or in a medical office, using a dedicated kit. This technique allows for the collection of vaginal cells using a specific medical device.
The vaginal veil with applicator (which works similarly to a tampon with applicator) is the preferred tool.
There is also the option of using a vaginal swab (comparable to the nasal swab used for Covid tests, but designed for vaginal use), although it has lower cell collection efficiency.
Using the vaginal veil is an easy, quick, and completely painless procedure.

  • Chlamydia trachomatis is the primary bacterial agent causing urogenital chlamydia. This STI can cause various genital symptoms, particularly in women, although many patients are asymptomatic carriers without knowing it. However, early detection enables effective treatment with antibiotics.
  • Neisseria gonorrhoeae (gonococcus) is a highly transmissible bacterium that causes gonococcal infection, also known as blennorrhagia or gonorrhea. In women, these gonococcal infections often remain silent or produce no identifiable clinical signs until complications arise.
  • Genital mycoplasmas refer to tiny bacteria that are ubiquitous in the environment. Regarding Mycoplasma genitalium, its detection is considered clinically significant. In women, Mycoplasma genitalium is involved in various conditions of the female genital tract, including cervicitis, urethritis, and pelvic inflammatory disease.
  • Trichomonas vaginalis is a human parasite of the protozoan class, responsible for a sexually transmitted infection that is usually benign. Trichomoniasis typically causes vulvovaginitis with often profuse vaginal discharge of varying odor, presenting a frothy appearance and greenish tint, sometimes whitish.
  • HPV (human papillomaviruses) are viruses that can trigger the development of cervical cancer. HPV infection is extremely common: approximately 80% of women contract this virus during their lifetime. In most cases, this infection clears up spontaneously. However, in 10% of cases, it can persist and cause cellular changes (precancerous lesions) on the cervix. These abnormalities may regress naturally or persist with a risk of progression to cervical cancer over time.
  • Vaginal flora imbalance : An imbalance (dysbiosis) of the vaginal microbiome is already correlated with multiple gynecological conditions as well as various pregnancy-related issues and assisted reproduction difficulties. The dysbiosis observed in these patients is characterized by a diverse and abundant vaginal microbiota, with an increased presence of bacteria associated with various intimate infections (bacterial vaginosis, vaginitis, cystitis) and, at the same time, a relative decrease in lactobacilli.” According to the data analyzed, the conception rate exceeded 72% when lactobacilli accounted for more than 90% of the vaginal microbiota, whereas it dropped to 34% when they were absent. The composition of the vaginal microbiota, particularly a deficiency in lactobacilli, appears to play a crucial role in repeated conception failures.
  • Endometriosis : In the presence of vaginal microbiome imbalance, the reduction or absence of certain bacteria (Atopobium, Gemella) combined with Gardnerella proliferation helps identify endometriosis risk markers as early as the onset of primary dysmenorrhea, prior to detection of salivary microRNA biomarkers through genomic analysis or PCR technique.

An STI refers to a sexually transmitted infection. It results from bacteria, viruses, or parasites and spreads easily during sexual intercourse. These infections do not always produce visible symptoms. That’s why regular screening is essential, even without visible symptoms, enabling early detection and preventing unintentional transmission. To guide you in selecting your tests, we recommend a remote medical consultation with specialized practitioners such as bleu.care (screening expert) who will identify the appropriate tests for your situation. These professionals rely on recent scientific advances and guidelines from leading medical organizations to offer you protocols and treatments with the highest level of scientific validation and optimal effectiveness in the screening field.

Bleu charges a service fee of €25 including tax for your complete care. This amount includes the issuance of your medical prescription, the initial consultation as well as communications with healthcare professionals, personalized interpretation of your results, and medical management if your results require intervention: therapeutic prescription, follow-up testing, or referral to an appropriate healthcare facility.

When your tests indicate an abnormality or pathological result (“positive”), it is essential to see a healthcare professional. The bleu.care medical team can support you and organize your medical follow-up to establish the necessary steps, fully included in your bleu.care journey.
The doctors will provide clinical support that may include appropriate treatment, a follow-up consultation, additional tests, or referral to a specialized healthcare facility.
You remain free to consult your primary care physician or another healthcare specialist.

Dépistage Auto-prélèvement vaginal
Scroll to Top